MediWound (MDWD)
(Real Time Quote from BATS)
$16.88 USD
-0.21 (-1.23%)
Updated Sep 17, 2025 01:32 PM ET
4-Sell of 5 4
F Value D Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MDWD 16.88 -0.21(-1.23%)
Will MDWD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MDWD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MDWD
MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates
Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates
MDWD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Stevanato Group (STVN) Q2 Earnings and Revenues Beat Estimates
Here's What Could Help MediWound (MDWD) Maintain Its Recent Price Strength
MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates
Other News for MDWD
Is MDWD signaling selling opportunity? 20 Day Moving Average Resistance shows up after slipping 0.29%
Fell Below 20 Day Moving Average appears for MDWD after 3.92% move
Fell Below 50 Day Moving Average appears for MDWD after 6.4% move
Is MDWD signaling a buying opportunity? Crossed Above 50 Day Moving Average shows up after climbing 3.31%
Crossed Above 20 Day Moving Average appears for MDWD after 13.26% move